Your search returned 170 studies:
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Chicago, Illinois
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Conditions: Leukemia, Myelogenous, Chronic - Leukemia, Lymphoblastic, Acute - Leukemia, Myelogenous, Acute - Myeloproliferative-Myelodysplastic Diseases - Lymphoma, Malignant
Location: Chicago, Illinois
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Chicago, Illinois
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Chicago, Illinois
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Chicago, Illinois
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Oak Lawn, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Chicago, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Chicago, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Chicago, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Chicago, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Elgin, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Highland Park, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Libertyville, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Maywood, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Niles, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Skokie, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Warrenville, Illinois
- Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Conditions: Leukemia - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
Location: Chicago, Illinois
- Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
Conditions: Refractory Cutaneous T-cell Lymphoma
Location: Chicago, Illinois
- Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)
Conditions: Lymphoma, T-Cell, Cutaneous
Location: Chicago, Illinois
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Maywood, Illinois
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Pa
Conditions: Diffuse Large B-cell Lymphoma
Location: Chicago, Illinois
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Pa
Conditions: Diffuse Large B-cell Lymphoma
Location: Maywood, Illinois
- Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
Conditions: Hodgkin's Lymphoma
Location: Maywood, Illinois
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
Location: Chicago, Illinois
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Maywood, Illinois
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Oak Lawn, Illinois
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Park Ridge, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Aurora, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Evanston, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Highland Park, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Libertyville, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Niles, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Skokie, Illinois
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Oak Lawn, Illinois
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Park Ridge, Illinois
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Chicago, Illinois
- Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Neuroblastoma - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Chicago, Illinois
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
Location: Chicago, Illinois
- Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Lymphoblastic Leukemia - Acute Leukemia - Non Hodgkins Lymphoma - Chronic Myeloid Leukemia
Location: Chicago, Illinois
- Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Conditions: Lymphoma - Lymphoproliferative Disorder
Location: Chicago, Illinois
- Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Conditions: Lymphoma - Lymphoproliferative Disorder
Location: Park Ridge, Illinois
- Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chicago, Illinois
- Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas
Conditions: Non-Hodgkin Lymphomas
Location: Niles, Illinois
- Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas
Conditions: Non-Hodgkin Lymphomas
Location: Park Ridge, Illinois
- Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
Conditions: Lymphoma
Location: Evanston, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Aurora, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Chicago, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Chicago, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Hinsdale, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Niles, Illinois
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Chicago, Illinois
- Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Conditions: Advanced Malignancies - B-Cell Lymphoma - Solid Tumor - Positive for Anaplastic Lymphoma Kinase - Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS
Location: Chicago, Illinois
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
Location: Chicago, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Highland Park, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Libertyville, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Niles, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Skokie, Illinois
- Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With P
Conditions: Chemotherapeutic Agent Toxicity - Cognitive/Functional Effects - Lymphoma - Neurotoxicity - Radiation Toxicity
Location: Chicago, Illinois
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphobl
Conditions: B-cell Childhood Acute Lymphoblastic Leukemia - Peripheral T-cell Lymphoma - Recurrent Childhood Acute Lymphoblastic Leukemia - Recurrent Childhood Lymphoblastic Lymphoma - T-cell Childhood Acute Lymphoblastic Leukemia
Location: Chicago, Illinois
- A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Conditions: Lymphoma
Location: Maywood, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Chicago, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Chicago, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Highland Park, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Libertyville, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Maywood, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Niles, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Skokie, Illinois
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: Chicago, Illinois
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: Chicago, Illinois
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: Highland Park, Illinois
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: Libertyville, Illinois
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: Niles, Illinois
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mant
Conditions: Lymphoma - Neurotoxicity - Therapy-related Toxicity
Location: Skokie, Illinois
- Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Conditions: Follicular Lymphoma
Location: Chicago, Illinois
- Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma - Adult Lymphocyte Predominant Hodgkin Lymphoma - Adult Mixed Cellularity Hodgkin Lymphoma - Adult Nodular Sclerosis Hodgkin Lymphoma - Stage II Adult Hodgkin Lymphoma - Stage III Adult Hodgkin Lymphoma - Stage
Location: Chicago, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Chicago, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Chicago, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Highland Park, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Libertyville, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Maywood, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Niles, Illinois
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Skokie, Illinois
- Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Conditions: Follicular Lymphoma
Location: Niles, Illinois
- Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma
Conditions: Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma - Recurrent Mycosis Fungoides/Sezary Syndrome - Stage I Cutaneous T-cell Non-Hodgkin Lymphoma - Stage IA Mycosis Fungoides/Sezary Syndrome - Stage IB Mycosis Fungoides/Sezary Syndrome - Stage II Cutaneous T-
Location: Chicago, Illinois
- Study Evaluating CMC-544 Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)
Conditions: Lymphoma, B-Cell
Location: Chicago, Illinois
- Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Conditions: Lymphoma
Location: Evanston, Illinois
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Chicago, Illinois
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Chicago, Illinois
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Chicago, Illinois
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Maywood, Illinois
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Oak Lawn, Illinois
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Park Ridge, Illinois
- A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Conditions: Systemic Anaplastic Large-Cell Lymphoma - Neoplasms - Anaplastic Lymphoma Kinase, Human - NSCLC
Location: Chicago, Illinois
- Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgk
Conditions: Lymphoma
Location: Chicago, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Munster, Indiana
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Plasma Cell Neoplasm - Myelodysplastic Syndromes
Location: Maywood, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Michigan City, Indiana
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Chicago, Illinois
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Chicago, Illinois
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Chicago, Illinois
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Evanston, Illinois
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Merrillville, Indiana
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Westville, Indiana
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Geneva, Illinois
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Maywood, Illinois
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
Location: Warrenville, Illinois
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymp
Conditions: Lymphoma, Large-Cell, Diffuse
Location: Chicago, Illinois
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Chicago, Illinois
- Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa
Location: Chicago, Illinois
- Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa
Location: Harvey, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Chicago, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Evanston, Illinois
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Maywood, Illinois
- Autologous Transplant in HIV Patients (BMT CTN 0803)
Conditions: Lymphoma - HIV
Location: Chicago, Illinois
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Location: Chicago, Illinois
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Location: Skokie, Illinois
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
Conditions: Lymphoma, Follicular
Location: Skokie, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Michigan City, Indiana
- Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Location: Chicago, Illinois
- Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Location: Chicago, Illinois
- Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Location: Evanston, Illinois
- Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma
Location: Harvey, Illinois
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma - Contiguous Stage II Grade 2 Follicular Lymphoma - Contiguous Stage II Grade 3 Follicular Lymphoma - Noncontiguous Stage II Grade 1 Follicular Lymphoma - Noncontiguous Stage II Grade 2 Follicular Lymphoma -
Location: Westville, Indiana
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma - Contiguous Stage II Grade 2 Follicular Lymphoma - Contiguous Stage II Grade 3 Follicular Lymphoma - Noncontiguous Stage II Grade 1 Follicular Lymphoma - Noncontiguous Stage II Grade 2 Follicular Lymphoma -
Location: Chicago, Illinois
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma - Contiguous Stage II Grade 2 Follicular Lymphoma - Contiguous Stage II Grade 3 Follicular Lymphoma - Noncontiguous Stage II Grade 1 Follicular Lymphoma - Noncontiguous Stage II Grade 2 Follicular Lymphoma -
Location: Chicago, Illinois
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma - Contiguous Stage II Grade 2 Follicular Lymphoma - Contiguous Stage II Grade 3 Follicular Lymphoma - Noncontiguous Stage II Grade 1 Follicular Lymphoma - Noncontiguous Stage II Grade 2 Follicular Lymphoma -
Location: Chicago, Illinois
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma - Contiguous Stage II Grade 2 Follicular Lymphoma - Contiguous Stage II Grade 3 Follicular Lymphoma - Noncontiguous Stage II Grade 1 Follicular Lymphoma - Noncontiguous Stage II Grade 2 Follicular Lymphoma -
Location: Evanston, Illinois
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma - Contiguous Stage II Grade 2 Follicular Lymphoma - Contiguous Stage II Grade 3 Follicular Lymphoma - Noncontiguous Stage II Grade 1 Follicular Lymphoma - Noncontiguous Stage II Grade 2 Follicular Lymphoma -
Location: Harvey, Illinois
- Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia
Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma
Location: Chicago, Illinois
- A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell - Lymphoma, Large B-Cell, Diffuse - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
Location: Chicago, Illinois
- A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell - Lymphoma, Large B-Cell, Diffuse - Lymphoma, Non-Hodgkin - Lymphoma, T-Cell
Location: Chicago, Illinois
- A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)
Location: Skokie, Illinois
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
Location: Chicago, Illinois
- A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell
Conditions: Primary Cutaneous Anaplastic Large Cell Lymphoma, - Mycosis Fungoides - Cutaneous T-Cell Lymphoma
Location: Chicago, Illinois
- A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory
Conditions: Non-Hodgkin's Lymphoma
Location: Harvey, Illinois
- KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Conditions: Adult T-cell Leukemia-Lymphoma
Location: Chicago, Illinois
- A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma
Location: Chicago, Illinois
- A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Conditions: Hodgkin Disease
Location: Niles, Illinois
- A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Tr
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Chicago, Illinois
- An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participat
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Chicago, Illinois
- Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
Conditions: Cutaneous T-Cell Lymphoma
Location: Chicago, Illinois
- A Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Niles, Illinois
- A Study Evaluating the Efficacy and Safety of Idelalisib(GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-H
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Joliet, Illinois
- A Study Evaluating the Efficacy and Safety of Idelalisib(GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-H
Conditions: Indolent Non-Hodgkin's Lymphomas
Location: Niles, Illinois
- A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
Conditions: Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma - Diffuse Large B-cell Lymphoma - Indolent Non-Hodgkin's Lymphoma
Location: Niles, Illinois
- Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Contiguous Stage II Adult Burkitt Lymphoma - Contiguous Stage II Adult Diffuse Large Cell
Location: Chicago, Illinois
|